Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal PR Newswire CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of Dr. Ian Y. Liu as Senior Vice...